Lipopolysaccharide-induced NF-κB activation in human endothelial cells involves degradation of Iκbα but not Iκb̄

Experimental Cell Research

Volumn 243, Issue 2, 1998, Pages 425-433

  Zen, Katsuhiro ^a   Karsan, Aly ^b   Eunson, Thomas ^a   Yee, Esther ^a   Harlan, John M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Endothelial; Herbimycin A; I B ; Lipopolysaccharide; Tyrosine kinase

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

EID: 0032531208     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4162     Document Type: Article

References (62)

1. Dixit V. M., Green S., Sarma V., Holzman L. B., Wolf F. W., O'Rourke K., Ward P. A., Prochownik E. V., Marks R. M. Tumor necrosis factor-α induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J. Biol. Chem. 265:1990;2973-2978.
2. Opipari A. W. J., Hu H. M., Yabkowitz R., Dixit V. M. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267:1992;12424-12427.
3. Tewari M., Wolf F. W., Seldin M. F., O'Shea K. S., Dixit V. M., Turka L. A. Lymphoid expression and regulation of A20, an inhibitor of programmed cell death. J. Immunol. 154:1995;1699-1706.
4. Pohlman T. H., Harlan J. M. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell. Immunol. 119:1989;41-52.
5. Polunovsky V. A., Wendt C. H., Ingbar D. H., Peterson M. S., Bitterman P. B. Induction of endothelial cell apoptosis by TNF-α: Modulation by inhibitors of protein synthesis. Exp. Cell Res. 214:1994;584-594.
6. Cooper J. T., Stroka D. M., Brostjan C., Palmetshofer A., Bach F. H., Ferran C. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J. Biol. Chem. 271:1996;18068-18073.
7. Karsan A., Yee E., Harlan J. M. Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 271:1996;27201-27204.
8. Jaattela M., Mouritzen H., Elling F., Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J. Immunol. 156:1996;1166-1173.
9. Song H. Y., Rothe M., Goeddel D. V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. USA. 93:1996;6721-6725.
10. Vincenz C., Dixit V. M. 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J. Biol. Chem. 271:1996;20029-20034.
11. Baldwin A. S. J. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
12. Read M. A., Whitley M. Z., Williams A. J., Collins T. NF-κB and IκBα: An inducible regulatory system in endothelial activation. J. Exp. Med. 179:1994;503-512.
13. Read M. A., Neish A. S., Luscinskas F. W., Palombella V. J., Maniatis T., Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 2:1995;493-506.
14. Roff M., Thompson J., Rodriguez M. S., Jacque J. M., Baleux F., Arenzana S. F., Hay R. T. Role of IκBα ubiquitination in signal-induced activation of NF-κB in vivo. J. Biol. Chem. 271:1996;7844-7850.
15. Hsu H., Xiong J., Goeddel D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell. 81:1995;495-504.
16. Hsu H., Shu H. B., Pan M. G., Goeddel D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
17. Liu Z. G., Hsu H., Goeddel D. V., Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:1996;565-576.
18. Schutze S., Wiegmann K., Machleidt T., Kronke M. TNF-induced activation of NF-κB. Immunobiology. 193:1995;193-203.
19. Arditi M., Zhou J., Dorio R., Rong G. W., Goyert S. M., Kim K. S. Endotoxin-mediated endothelial cell injury and activation: Role of soluble CD14. Infect. Immun. 61:1993;3149-3156.
20. Frey E. A., Miller D. S., Jahr T. G., Sundan A., Bazil V., Espevik T., Finlay B. B., Wright S. D. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1992;1665-1671.
21. Haziot A., Rong G. W., Silver J., Goyert S. M. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1993;1500-1507.
22. Arditi M., Zhou J., Torres M., Durden D. L., Stins M., Kim K. S. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42, and p41 in vascular endothelial cells in a soluble CD14-dependent manner: Role of protein tyrosine phosphorylation in lipopolysaccharide-induced stimulation of endothelial cells. J. Immunol. 155:1995;3994-4003.
23. Schumann R. R., Pfeil D., Lamping N., Kirschning C., Scherzinger G., Schlag P., Karawajew L., Herrmann F. Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. Blood. 87:1996;2805-2814.
24. Zen K., Masuda J., Sasaguri T., Kosaka C., Ogata J. Gene expression of monocyte chemoattractant protein-1 in human monocytes is regulated by cell density through protein tyrosine kinase and protein kinase C. Exp. Cell Res. 215:1994;172-179.
25. Montgomery K. F., Osborn L., Hession C., Tizard R., Goff D., Vassallo C., Tarr P. I., Bomsztyk K., Lobb R., Harlan J. M., Pohlman T. H. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA. 88:1991;6523-6527.
26. Imbert V., Rupec R. A., Livolsi A., Pahl H. L., Traenckner E. B., Mueller D. C., Farahifar D., Rossi B., Auberger P., Baeuerle P. A., Peyron J. F. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α Cell. 86:1996;787-798.
27. Krikos A., Laherty C. D., Dixit V. M. Transcriptional activation of the tumor necrosis factor α-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol. Chem. 267:1992;17971-17976.
28. Weber C., Negrescu E., Erl W., Pietsch A., Frankenberger M., Ziegler-Heitbrock H. W., Siess W., Weber P. C. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J. Immunol. 155:1995;445-451.
29. Tebo J. M., Chaoqun W., Ohmori Y., Hamilton T. A. Murine inhibitory protein-κBα negatively regulates κB-dependent transcription in lipopolysaccharide-stimulated RAW 264.7 macrophages. J. Immunol. 153:1994;4713-4720.
30. Johnson D. R., Douglas I., Jahnke A., Ghosh S., Pober J. S. A sustained reduction in IκB-β may contribute to persistent NF-κB activation in human endothelial cells. J. Biol. Chem. 271:1996;16317-16322.
31. Beauparlant P., Lin R., Hiscott J. The role of the C-terminal domain of IκBα in protein degradation and stabilization. J. Biol. Chem. 271:1996;10690-10696.
32. Koong A. C., Chen E. Y., Mivechi N. F., Denko N. C., Stambrook P., Giaccia A. J. Hypoxic activation of nuclear factor-κB is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res. 54:1994;5273-5279.
33. Sweet M. J., Hume D. A. Endotoxin signal transduction in macrophages. J. Leukocyte Biol. 60:1996;8-26.
34. Adamson P., Tighe M., Pearson J. D. Protein tyrosine kinase inhibitors act downstream of IL-1α and LPS stimulated MAP-kinase phosphorylation to inhibit expression of E-selectin on human umbilical vein endothelial cells. Cell Adhes. Commun. 3:1996;511-525.
35. Cuenda A., Rouse J., Doza Y. N., Meier R., Cohen P., Gallagher T. F., Young P. R., Lee J. C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
36. Pietersma A., Tilly B. C., Gaestel M., de J. N., Lee J. C., Koster J. F., Sluiter W. p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem. Biophys. Res. Commun. 230:1997;44-48.
37. Waters S. B., Holt K. H., Ross S. E., Syu L. J., Guan K. L., Saltiel A. R., Koretzky G. A., Pessin J. E. Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J. Biol. Chem. 270:1995;20883-20886.
38. Bell S., Matthews J. R., Jaffray E., Hay R. T. IκBγ inhibits DNA binding of NF-κB p50 homodimers by interacting with residues that contact DNA. Mol. Cell Biol. 16:1996;6477-6485.
39. Thompson J. E., Phillips R. J., Erdjument B. H., Tempst P., Ghosh S. IκB-β regulates the persistent response in a biophasic activation of NF-κB. Cell. 80:1995;573-582.
40. Marsh C. B., Moore S. A., Pope H. A., Wewers M. D. IL-1ra suppresses endotoxin-induced IL-1β and TNF-α release from mononuclear phagocytes. Am. J. Physiol. 267:1994;39-45.
41. Cobb R. R., Felts K. A., Parry G. C., Mackman N. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-κB. Eur. J. Immunol. 26:1996;839-845.
42. Delude R. L., Fenton M. J., Savedra R. J., Perera P. Y., Vogel S. N., Thieringer R., Golenbock D. T. CD14-mediated translocation of nuclear factor-κB induced by lipopolysaccharide does not require tyrosine kinase activity. J. Biol. Chem. 269:1994;22253-22260.
43. Mahon T. M., O'Neill L. A. Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-κB activation in T lymphocytes: Evidence for covalent modification of the p50 subunit. J. Biol. Chem. 270:1995;28557-28564.
44. Takahashi M., Berk B. C. Mitogen-activated protein kinase (ERK1/2) activation by shear stress and adhesion in endothelial cells: Essential role for a herbimycin-sensitive kinase. J. Clin. Invest. 98:1996;2623-2631.
45. Chen Z. J., Parent L., Maniatis T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862.
46. Bennett B. L., Lacson R. G., Chen C. C., Cruz R., Wheeler J. S., Kletzein R. F., Tomasselli A. G., Heinrikson R. L., Manning A. M. Identification of signal-induced IκB-α kinases in human endothelial cells. J. Biol. Chem. 271:1996;19680-19688.
47. Janosch P., Schellerer M., Seitz T., Reim P., Eulitz M., Brielmeier M., Kolch W., Sedivy J. M., Mischak H. Characterization of IκB kinases. IκB-α is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate. J. Biol. Chem. 271:1996;13868-13874.
48. Sanghera J. S., Weinstein S. L., Aluwalia M., Girn J., Pelech S. L. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J. Immunol. 156:1996;4457-4465.
49. Hirano M., Osada S., Aoki T., Hirai S., Hosaka M., Inoue J., Ohno S. MEK kinase is involved in tumor necrosis factor α-induced NF-κB activation and degradation of IκB-α J. Biol. Chem. 271:1996;13234-13238.
50. Hambleton J., Weinstein S. L., Lem L., DeFranco A. L. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA. 93:1996;2774-2778.
51. Modur V., Zimmerman G. A., Prescott S. M., McIntyre T. M. Endothelial cell inflammatory responses to tumor necrosis factor-α: Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J. Biol. Chem. 271:1996;13094-13102.
52. Cano E., Hazzalin C. A., Mahadevan L. C. Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol. Cell Biol. 14:1994;7352-7362.
53. Claudio E., Segade F., Wrobel K., Ramos S., Bravo R., Lazo P. S. Molecular mechanisms of TNFα cytotoxicity: Activation of NF-κB and nuclear translocation. Exp. Cell Res. 224:1996;63-71.
54. Lee F. S., Hagler J., Chen Z. J., Maniatis T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
55. Meyer C. F., Wang X., Chang C., Templeton D., Tan T. H. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating κB enhancer activation. J. Biol. Chem. 271:1996;8971-8976.
56. Malinin N. L., Boldin M. P., Kovalenko A. V., Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
57. DiDonato J. A., Hayakawa M., Rothwarf D. M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554.
58. R'egnier C. H., Song H. Y., Gao X., Goeddel D. V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
59. 14. FEBS Lett. 340:1994;155-158.
60. Herrera V. P., Reiner N. E. Bacterial lipopolysaccharide induces the association and coordinate activation of p53/56lyn and phosphatidylinositol 3-kinase in human monocytes. J. Immunol. 156:1996;1157-1165.
61. Stefanova, Corcoran M. L., Horak E. M., Wahl L. M., Bolen J. B., Horak I. D. Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J. Biol. Chem. 268:1993;20725-20728.
62. Meng F., Lowell C. A. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J. Exp. Med. 185:1997;1661-1670.